René M M van Aerts1, Wietske Kievit1, Michiel E de Jong1, Curie Ahn2, Jesús M Bañales3, Jana Reiterová4, Frederik Nevens5, Joost P H Drenth1. 1. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. 2. Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. 3. Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute-Donostia University Hospital, IKERBASQUE, CIBERehd, University of the Basque Country (UPV/EHU), San Sebastián, Spain. 4. Department of Nephrology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. 5. Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Leuven, Belgium.
Abstract
BACKGROUND & AIMS: Polycystic liver disease (PLD) occurs in two genetic disorders, autosomal-dominant polycystic kidney disease (ADPKD) and autosomal-dominant polycystic liver disease (ADPLD). The aim of this study is to compare disease severity between ADPKD and ADPLD by determining the association between diagnosis and height-adjusted total liver volume (hTLV). METHODS: We performed a cross-sectional analysis with hTLV as endpoint. Patients were identified from the International PLD Registry (>10 liver cysts) and included in our analysis when PLD diagnosis was made prior to September 2017, hTLV was available before volume-reducing therapy (measured on computed tomography or magnetic resonance imaging) and when patients were tertiary referred. Data from the registry were retrieved for age, diagnosis (ADPKD or ADPLD), gender, height and hTLV. RESULTS: A total of 360 patients (ADPKD n = 241; ADPLD n = 119) met our inclusion criteria. Female ADPKD patients had larger hTLV compared with ADPLD (P = 0.008). In a multivariate regression analysis, ADPKD and lower age at index CT were independently associated with larger hTLV in females, whereas in males a higher age was associated with larger hTLV. Young females (≤51 years) had larger liver volumes compared with older females (>51 years) in ADPKD. CONCLUSION: Aetiology is presented as a new risk factor associated with PLD severity. Young females with ADPKD represent a subgroup of PLD patients with the most severe phenotype expressed in hTLV.
BACKGROUND & AIMS:Polycystic liver disease (PLD) occurs in two genetic disorders, autosomal-dominant polycystic kidney disease (ADPKD) and autosomal-dominant polycystic liver disease (ADPLD). The aim of this study is to compare disease severity between ADPKD and ADPLD by determining the association between diagnosis and height-adjusted total liver volume (hTLV). METHODS: We performed a cross-sectional analysis with hTLV as endpoint. Patients were identified from the International PLD Registry (>10 liver cysts) and included in our analysis when PLD diagnosis was made prior to September 2017, hTLV was available before volume-reducing therapy (measured on computed tomography or magnetic resonance imaging) and when patients were tertiary referred. Data from the registry were retrieved for age, diagnosis (ADPKD or ADPLD), gender, height and hTLV. RESULTS: A total of 360 patients (ADPKD n = 241; ADPLD n = 119) met our inclusion criteria. Female ADPKDpatients had larger hTLV compared with ADPLD (P = 0.008). In a multivariate regression analysis, ADPKD and lower age at index CT were independently associated with larger hTLV in females, whereas in males a higher age was associated with larger hTLV. Young females (≤51 years) had larger liver volumes compared with older females (>51 years) in ADPKD. CONCLUSION: Aetiology is presented as a new risk factor associated with PLD severity. Young females with ADPKD represent a subgroup of PLD patients with the most severe phenotype expressed in hTLV.
Authors: Sophie E Aapkes; Lucas H P Bernts; M van den Berg; Ron T Gansevoort; Joost P H Drenth Journal: Medicine (Baltimore) Date: 2021-08-13 Impact factor: 1.817
Authors: Paula Olaizola; Pedro M Rodrigues; Francisco J Caballero-Camino; Laura Izquierdo-Sanchez; Patricia Aspichueta; Luis Bujanda; Nicholas F Larusso; Joost P H Drenth; Maria J Perugorria; Jesus M Banales Journal: Nat Rev Gastroenterol Hepatol Date: 2022-05-13 Impact factor: 73.082
Authors: René M M van Aerts; Lucas H P Bernts; Tom J G Gevers; Wietske Kievit; Lisanne Koopmans; Theodoor E Nieboer; Frederik Nevens; Joost P H Drenth Journal: Clin Pharmacol Ther Date: 2019-07-23 Impact factor: 6.875
Authors: Xiaorui Yin; Jon D Blumenfeld; Sadjad Riyahi; Xianfu Luo; Hanna Rennert; Irina Barash; Martin R Prince Journal: Kidney Int Rep Date: 2020-11-01
Authors: S E Aapkes; L H P Bernts; A P van den Berg; M van den Berg; H Blokzijl; A E P Cantineau; M D A van Gastel; R J de Haas; P Kappert; R U Müller; F Nevens; R Torra; A Visser; J P H Drenth; R T Gansevoort Journal: BMC Gastroenterol Date: 2022-02-25 Impact factor: 3.067
Authors: Dana Sierks; Ria Schönauer; Anja Friedrich; Elena Hantmann; Jonathan de Fallois; Nikolas Linder; Janett Fischer; Adam Herber; Carsten Bergmann; Thomas Berg; Jan Halbritter Journal: JHEP Rep Date: 2022-09-08